We are live on ! Find out more
DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B Turnover 6.98%
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
+3.88%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
–
AUM
$774M
AUM Growth
+$15.3M
Cap. Flow
-$9.61M
Cap. Flow %
-1.24%
Top 10 Hldgs %
26.39%
Holding
284
New
7
Increased
63
Reduced
151
Closed
12
Avg Time Held
0.9 years
Top 10 Avg Time Held
0.9 years
Top 20 Avg Time Held
0.9 years

Top Buys

Rank Stock Value
1
IBKR icon
Interactive Brokers
IBKR
+$920K
2
AAPL icon
Apple
AAPL
+$848K
3
CAT icon
Caterpillar
CAT
+$737K
4
VAW icon
Vanguard Materials ETF
VAW
+$304K
5
IBM icon
IBM
IBM
+$298K

Top Sells

Rank Stock Value
1
KO icon
Coca-Cola
KO
+$978K
2
RS icon
Reliance Steel & Aluminium
RS
+$643K
3
NBIX icon
Neurocrine Biosciences
NBIX
+$483K
4
ACO
AMCOL International Corp
ACO
+$483K
5
JNJ icon
Johnson & Johnson
JNJ
+$450K

Sector Composition

Rank Sector Weight
1 Miscellaneous 20.26%
2 Healthcare 13.17%
3 Consumer Staples 12.92%
4 Technology 11.77%
5 Financials 10.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
XLV icon
226
State Street Health Care Select Sector SPDR ETF
XLV
$45.9B
$332K 0.04%
5,453
– –
2013 Q2
4 quarters
SCZ icon
227
iShares MSCI EAFE Small-Cap ETF
SCZ
$12.7B
$325K 0.04%
6,147
– –
2013 Q2
4 quarters
INFU icon
228
InfuSystem Holdings
INFU
$277M
$305K 0.04%
115,000
– –
2013 Q2
4 quarters
CRM icon
229
Salesforce
CRM
$203B
$289K 0.04%
4,984
+750
+18% +$40.5K
2013 Q3
3 quarters
ACTG icon
230
Acacia Research
ACTG
$413M
$287K 0.04%
16,190
– –
2013 Q2
4 quarters
GLD icon
231
SPDR Gold Trust
GLD
$142B
$280K 0.04%
2,185
+125
+6% +$15.5K
2013 Q2
4 quarters
PCP
232
DELISTED
PRECISION CASTPARTS CORP
PCP
$275K 0.04%
1,090
-125
-10% -$32K
2013 Q2
4 quarters
WOR icon
233
Worthington Enterprises
WOR
$3.14B
$271K 0.04%
10,223
– –
2013 Q2
4 quarters
VOO icon
234
Vanguard S&P 500 ETF
VOO
$1.05T
$256K 0.03%
1,429
– –
2014 Q1
1 quarter
FISV icon
235
Fiserv Inc
FISV
$25.1B
$255K 0.03%
8,462
-1,020
-11% -$30.2K
2013 Q2
4 quarters
SCHW icon
236
Charles Schwab
SCHW
$163B
$255K 0.03%
9,480
-1,981
-17% -$52K
2013 Q2
4 quarters
AMRC icon
237
Ameresco
AMRC
$1.07B
$254K 0.03%
36,200
-1,000
-3% -$6.77K
2014 Q1
1 quarter
IVE icon
238
iShares S&P 500 Value ETF
IVE
$49.9B
$254K 0.03%
2,809
-128
-4% -$11.3K
2013 Q3
3 quarters
MO icon
239
Altria Group
MO
$123B
$254K 0.03%
6,047
– –
2013 Q2
4 quarters
NBL
240
DELISTED
Noble Energy, Inc.
NBL
$252K 0.03%
3,250
– –
2013 Q2
4 quarters
A icon
241
Agilent Technologies
A
$49.5B
$247K 0.03%
6,016
-104
-2% -$4.18K
2013 Q3
3 quarters
EPC icon
242
Edgewell Personal Care
EPC
$1.3B
$247K 0.03%
2,725
– –
2013 Q4
2 quarters
NVS icon
243
Novartis
NVS
$286B
$245K 0.03%
3,025
+296
+11% +$23.3K
2014 Q1
1 quarter
XLE icon
244
State Street Energy Select Sector SPDR ETF
XLE
$42.8B
$244K 0.03%
4,874
-400
-8% -$18.9K
2013 Q3
3 quarters
HII icon
245
Huntington Ingalls Industries
HII
$10.5B
$241K 0.03%
2,547
– –
2013 Q4
2 quarters
IYC icon
246
iShares US Consumer Discretionary ETF
IYC
$1.23B
$232K 0.03%
7,500
-200
-3% -$6.02K
2013 Q3
3 quarters
DXCM icon
247
DexCom
DXCM
$33.1B
$229K 0.03%
23,048
+3,048
+15% +$27K
2014 Q1
1 quarter
SDY icon
248
State Street SPDR S&P Dividend ETF
SDY
$21.4B
$229K 0.03%
2,990
– –
2013 Q4
2 quarters
ACAD icon
249
Acadia Pharmaceuticals
ACAD
$3.4B
$226K 0.03%
10,000
– –
2013 Q2
4 quarters
VIG icon
250
Vanguard Dividend Appreciation ETF
VIG
$113B
$226K 0.03%
2,904
-1,343
-32% -$103K
2014 Q1
1 quarter
7 8 9
10
11

Similar funds

AC
Alleghany Corporation New York $2.21B AUM 10.5% 1-Year Est. Return
Covington Capital Management
Covington Capital Management Los Angeles, California $2.32B AUM 12.18% 1-Year Est. Return
Mariner Independent Advisor Network
Mariner Independent Advisor Network Overland Park, Kansas $2.33B AUM 14.85% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return
IC
Inverness Counsel New York $1.8B AUM 9.9% 1-Year Est. Return
SCA
Salient Capital Advisors Houston, Texas $1.74B AUM 12.95% 1-Year Est. Return
ACM
AlphaCrest Capital Management New York $1.64B AUM 23.4% 1-Year Est. Return
W
Wealthsimple Toronto, Ontario, Canada $2.69B AUM 18.39% 1-Year Est. Return

Dowling & Yahnke's Q2 2014 Portfolio in Review

As of Q2 2014, Dowling & Yahnke held 284 positions worth $774M, up 2% from $759M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Dowling & Yahnke's Q2 2014 filing shows 7 new, 63 increased, 151 reduced and 12 closed positions. Its largest new stake was Allergan plc: 949 shares worth $212K. The largest sale was Coca-Cola, an estimated $978K.

By sector, the portfolio is most concentrated in Miscellaneous at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Dowling & Yahnke's largest Q2 2014 buy was Allergan plc: 949 shares worth $212K.
  • Dowling & Yahnke added most to Interactive Brokers in Q2 2014, an estimated $920K increase.
  • Dowling & Yahnke's biggest Q2 2014 reduction was Coca-Cola, cutting an estimated $978K.
  • Dowling & Yahnke fully exited AMCOL International Corp in Q2 2014, selling an estimated $483K.
  • Dowling & Yahnke's ten largest holdings make up 26% of its $774M portfolio in Q2 2014.
  • Dowling & Yahnke opened 7 new positions and closed 12 in Q2 2014.
  • Dowling & Yahnke's portfolio value rose 2% quarter-over-quarter to $774M.

Based on Dowling & Yahnke's 13F filing for Q2 2014, filed 15 Aug 2014.